Search

  • HOME
  • Search
Letter to the Editor
1672
Clinical significance of the discrepancy between radiological findings and biochemical responses in atezolizumab plus bevacizumab for hepatocellular carcinoma
Hideki Iwamoto, Shigeo Shimose, Takashi Niizeki, Hironori Koga, Takuji Torimura
Clin Mol Hepatol. 2022;28(3):575-579.   Published online April 21, 2022
View: 796   Download: 137
Original Article
1676
Gut-derived lipopolysaccharide promotes alcoholic hepatosteatosis and subsequent hepatocellular carcinoma by stimulating neutrophil extracellular traps through toll-like receptor 4
Yang Liu, Xin Zhang, Shuo Chen, Jiazhong Wang, Shuo Yu, Yiming Li, Meng Xu, Harouna Aboubacar, Junhui Li, Tao Shan, Jixin Wang, Gang Cao
Clin Mol Hepatol. 2022;28(3):522-539.   Published online May 4, 2022
View: 929   Download: 70  Citation: 1
Review
1658
Intrahepatic cholangiocarcinoma: Tumour heterogeneity and its clinical relevance
Mina Komuta
Clin Mol Hepatol. 2022;28(3):396-407.   Published online January 14, 2022
View: 1523   Download: 204  Citation: 1
Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?
Myung Ji Goh, Dong Hyun Sinn
Clin Mol Hepatol. 2022;28(3):380-395.   Published online January 13, 2022
View: 1188   Download: 88
1651
Imaging diagnosis of hepatocellular carcinoma: Future directions with special emphasis on hepatobiliary magnetic resonance imaging and contrast-enhanced ultrasound
Junghoan Park, Jeong Min Lee, Tae-Hyung Kim, Jeong Hee Yoon
Clin Mol Hepatol. 2022;28(3):362-379.   Published online December 27, 2021
View: 1322   Download: 129
1647
The best predictive model for hepatocellular carcinoma in patients with chronic hepatitis B infection
Jung Hwan Yu, Soon Gu Cho, Young-Joo Jin, Jin-Woo Lee
Clin Mol Hepatol. 2022;28(3):351-361.   Published online November 26, 2021
View: 1551   Download: 129
Original Article
Surgery versus radiofrequency ablation in patients with Child- Pugh class-A/single small (≤3 cm) hepatocellular carcinoma
Jungnam Lee, Young-Joo Jin, Seung Kak Shin, Jung Hyun Kwon, Sang Gyune Kim, Young Ju Suh, Yujin Jeong, Jung Hwan Yu, Jin-Woo Lee, Oh Sang Kwon, Soon Woo Nahm, Young Seok Kim
Clin Mol Hepatol. 2022;28(2):207-218.   Published online November 24, 2021
View: 1758   Download: 142  Citation: 1
Editorial
Surgical resection versus ablation for early hepatocellular carcinoma: The debate is still open
Bo Hyun Kim
Clin Mol Hepatol. 2022;28(2):174-176.   Published online January 26, 2022
View: 1078   Download: 59
Review
1637
The management of post-transplantation recurrence of hepatocellular carcinoma
Luckshi Rajendran, Tommy Ivanics, Marco PAW Claasen, Hala Muaddi, Gonzalo Sapisochin
Clin Mol Hepatol. 2022;28(1):1-16.   Published online October 5, 2021
View: 2944   Download: 178
Original Article
1625
Impact of everolimus on survival after liver transplantation for hepatocellular carcinoma
Incheon Kang, Jae Geun Lee, Sung Hoon Choi, Hyun Jeong Kim, Dai Hoon Han, Gi Hong Choi, Myoung Soo Kim, Jin Sub Choi, Soon Il Kim, Dong Jin Joo
Clin Mol Hepatol. 2021;27(4):589-602.   Published online July 23, 2021
View: 2350   Download: 171  Citations: 5
Editorial
Can hepatocellular carcinoma recurrence be prevented after liver transplantation?
Jong Man Kim
Clin Mol Hepatol. 2021;27(4):562-563.   Published online September 23, 2021
View: 1550   Download: 86  Citation: 1
Review
1606
Three heads are better than two: Hepatitis B core-related antigen as a new predictor of hepatitis B virus-related hepatocellular carcinoma
Jer-Wei Wu, Jia-Horng Kao, Tai-Chung Tseng
Clin Mol Hepatol. 2021;27(4):524-534.   Published online February 23, 2021
View: 9655   Download: 266  Citations: 7
Special Topic
Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline
Ju-Yeon Cho, Young-Sun Lee, Soon Sun Kim, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim
Clin Mol Hepatol. 2021;27(4):515-523.   Published online September 17, 2021
View: 2967   Download: 55  Citation: 1
Snapshot
1618
Hepatocellular carcinoma statistics in South Korea
Young Eun Chon, Soung Won Jeong, Dae Won Jun
Clin Mol Hepatol. 2021;27(3):512-514.   Published online June 21, 2021
View: 2439   Download: 115  Citations: 7
Letter to the Editor
How long should physicians follow up with patients after curative treatment for hepatocellular carcinoma?
Bo Hyun Kim
Clin Mol Hepatol. 2019;26(4):579-581.   Published online September 23, 2020
View: 1889   Download: 59  Citations: 2
Original Article
The association of the serum levels of myostatin, follistatin, and interleukin-6 with sarcopenia, and their impacts on survival in patients with hepatocellular carcinoma
Kanghyug Choi, Hee Yoon Jang, Joong Mo Ahn, Sung Ho Hwang, Jung Wha Chung, Yun Suk Choi, Jin-Wook Kim, Eun Sun Jang, Gwang Hyeon Choi, Sook-Hyang Jeong
Clin Mol Hepatol. 2020;26(4):492-505.   Published online July 10, 2020
View: 10180   Download: 252  Citations: 16
Editorial
Low-level viremia in patients undergoing antiviral therapy: Does it indicate time for a change?
Jung Hee Kim, Dong Hyun Sinn
Clin Mol Hepatol. 2020;26(3):315-317.   Published online June 23, 2020
View: 2623   Download: 85
Original Article
Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection
Hye Soo Kim, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Young Nyun Park, Dai Hoon Han, Kyung Sik Kim, Jin Sub Choi, Gi Hong Choi, Hyon-Suk Kim
Clin Mol Hepatol. 2020;26(1):33-44.   Published online June 27, 2019
View: 4022   Download: 163  Citations: 8
Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B
Haneulsaem Shin, Yeon Woo Jung, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Yeun-Yoon Kim, Jin-Young Choi, Seung Up Kim
Clin Mol Hepatol. 2019;25(4):390-399.   Published online May 31, 2019
View: 3881   Download: 132  Citations: 17
1461
Ultraselective conventional transarterial chemoembolization: When and how?
Shiro Miyayama
Clin Mol Hepatol. 2019;25(4):344-353.   Published online April 26, 2019
View: 7693   Download: 489  Citations: 20
1457
Detect or not to detect very early stage hepatocellular carcinoma? The western perspective
Ju Dong Yang
Clin Mol Hepatol. 2019;25(4):335-343.   Published online March 29, 2019
View: 7393   Download: 185  Citations: 26
Original Article
Underlying liver disease and advanced stage liver cancer are associated with elevated neutrophil-lymphocyte ratio
Linda Wong, Kliment Bozhilov, Brenda Hernandez, Sandi Kwee, Owen Chan, Luke Ellis, Loic LeMarchand
Clin Mol Hepatol. 2019;25(3):305-316.   Published online April 19, 2019
View: 4236   Download: 148  Citations: 15
Review
Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?
Ibrahim A. Hanouneh, Naim Alkhouri, Amit G. Singal
Clin Mol Hepatol. 2019;25(3):264-269.   Published online March 4, 2019
View: 6596   Download: 298  Citations: 33
1448
Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update
Tae-Hyung Kim, So Yeon Kim, An Tang, Jeong Min Lee
Clin Mol Hepatol. 2019;25(3):245-263.   Published online February 14, 2019
View: 13296   Download: 928  Citations: 111
1442
Gadoxetic acid-enhanced magnetic resonance imaging: Hepatocellular carcinoma and mimickers
Yeun-Yoon Kim, Mi-Suk Park, Khalid Suliman Aljoqiman, Jin-Young Choi, Myeong-Jin Kim
Clin Mol Hepatol. 2019;25(3):223-233.   Published online January 21, 2019
View: 6966   Download: 353  Citations: 24
1447
Unmet need in chronic hepatitis B management
Lilian Yan Liang, Grace Lai-Hung Wong
Clin Mol Hepatol. 2019;25(2):172-180.   Published online February 12, 2019
View: 6673   Download: 366  Citations: 40
Direct-acting antivirals response in hepatocellular carcinoma: Does the presence of hepatocellular carcinoma matter?
Chung-Feng Huang, Ming-Lung Yu
Clin Mol Hepatol. 2019;25(2):168-171.   Published online February 11, 2019
View: 4235   Download: 173  Citations: 4
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 |

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X


Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 273
TOTAL : 924054
Close layer